The Onion

Onion Therapeutics is a biotechnology company developing a programmable medicine platform designed to enable tissue-specific delivery of genetic medicines. The company's technology focuses on overcoming the limitations of current delivery systems, such as lipid nanoparticles (LNPs), by engineering vehicles that can precisely target organs beyond the liver. By integrating advanced molecular engineering with high-throughput screening, Onion aims to create a new class of genetic therapies for a wide range of indications, including rare genetic disorders and cancer. The company operates primarily in stealth or early-stage development, leveraging expertise in delivery science to expand the reach of genomic medicine.